Xtant Medical Holdings
XTNT
17 hedge funds and large institutions have $4.03M invested in Xtant Medical Holdings in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
6% less funds holding
Funds holding: 18 → 17 (-1)
25% less capital invested
Capital invested by funds: $5.4M → $4.03M (-$1.37M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
+$277K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$86.3K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.32K |
| 4 |
Morgan Stanley
New York
|
+$1.47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$206 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$60K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$38.6K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$13.5K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$6.88K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.51K |
XTNT Hedge Fund Activity: Q2 2016 in Review
17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2016, worth a combined $4.03M — down 25% from $5.4M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of XTNT and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Goldman Capital Management, adding an estimated $277K. The largest seller was Millennium Management, exiting entirely with an estimated $60K sold.
- 17 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2016, down from 18 in Q1 2016.
- Funds reported $4.03M of Xtant Medical Holdings stock for Q2 2016, down 25% quarter-over-quarter.
- 2 funds opened new Xtant Medical Holdings positions in Q2 2016 and 3 closed out, a net change of -1 holder.
- The largest Xtant Medical Holdings buyer in Q2 2016 was Goldman Capital Management, an estimated $277K added.
- The largest Xtant Medical Holdings seller in Q2 2016 was Millennium Management, an estimated $60K sold.
Based on aggregated 13F filings for Q2 2016.